Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74


Individual differences in the neuropsychopathology of addiction.

George O, Koob GF.

Dialogues Clin Neurosci. 2017 Sep;19(3):217-229.


Dissociable Role of Corticotropin Releasing Hormone Receptor Subtype 1 on Dopaminergic and D1 Dopaminoceptive Neurons in Cocaine Seeking Behavior.

Bernardi RE, Broccoli L, Hirth N, Justice NJ, Deussing JM, Hansson AC, Spanagel R.

Front Behav Neurosci. 2017 Nov 13;11:221. doi: 10.3389/fnbeh.2017.00221. eCollection 2017.


Comorbidity of Alcohol Use Disorder and Chronic Pain: Genetic Influences on Brain Reward and Stress Systems.

Yeung EW, Craggs JG, Gizer IR.

Alcohol Clin Exp Res. 2017 Nov;41(11):1831-1848. doi: 10.1111/acer.13491. Epub 2017 Oct 19. Review.


21st century neurobehavioral theories of decision making in addiction: Review and evaluation.

Bickel WK, Mellis AM, Snider SE, Athamneh LN, Stein JS, Pope DA.

Pharmacol Biochem Behav. 2018 Jan;164:4-21. doi: 10.1016/j.pbb.2017.09.009. Epub 2017 Sep 21. Review.


The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?

Pomrenze MB, Fetterly TL, Winder DG, Messing RO.

Alcohol Clin Exp Res. 2017 Dec;41(12):1986-1999. doi: 10.1111/acer.13507. Epub 2017 Oct 25. Review.


Emerging pharmacotherapies for alcohol use disorder.

Mason BJ.

Neuropharmacology. 2017 Aug 1;122:244-253. doi: 10.1016/j.neuropharm.2017.04.032. Epub 2017 Apr 25. Review.


Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development.

Negus SS, Banks ML.

Pharmacol Biochem Behav. 2018 Jan;164:32-39. doi: 10.1016/j.pbb.2017.04.006. Epub 2017 Apr 22. Review.


Alcohol Dependence Disrupts Amygdalar L-Type Voltage-Gated Calcium Channel Mechanisms.

Varodayan FP, de Guglielmo G, Logrip ML, George O, Roberto M.

J Neurosci. 2017 Apr 26;37(17):4593-4603. doi: 10.1523/JNEUROSCI.3721-16.2017. Epub 2017 Mar 31.


Don't stress about CRF: assessing the translational failures of CRF1antagonists.

Spierling SR, Zorrilla EP.

Psychopharmacology (Berl). 2017 May;234(9-10):1467-1481. doi: 10.1007/s00213-017-4556-2. Epub 2017 Mar 7. Review.


An Update on CRF Mechanisms Underlying Alcohol Use Disorders and Dependence.

Quadros IM, Macedo GC, Domingues LP, Favoretto CA.

Front Endocrinol (Lausanne). 2016 Oct 21;7:134. eCollection 2016. Review.


Perspectives on stress resilience and adolescent neurobehavioral function.

Romeo RD.

Neurobiol Stress. 2014 Nov 8;1:128-33. doi: 10.1016/j.ynstr.2014.11.001. eCollection 2015 Jan. Review.


Early life stress is a risk factor for excessive alcohol drinking and impulsivity in adults and is mediated via a CRF/GABA(A) mechanism.

Gondré-Lewis MC, Warnock KT, Wang H, June HL Jr, Bell KA, Rabe H, Tiruveedhula VV, Cook J, Lüddens H, Aurelian L, June HL Sr.

Stress. 2016;19(2):235-47. doi: 10.3109/10253890.2016.1160280. Epub 2016 Mar 29.


Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics.

Ubaldi M, Cannella N, Ciccocioppo R.

Prog Brain Res. 2016;224:251-84. doi: 10.1016/bs.pbr.2015.07.018. Epub 2015 Nov 26. Review.


Glutamatergic transmission in the central nucleus of the amygdala is selectively altered in Marchigian Sardinian alcohol-preferring rats: Alcohol and CRF effects.

Herman MA, Varodayan FP, Oleata CS, Luu G, Kirson D, Heilig M, Ciccocioppo R, Roberto M.

Neuropharmacology. 2016 Mar;102:21-31. doi: 10.1016/j.neuropharm.2015.10.027. Epub 2015 Oct 28.


The BDNF Valine 68 to Methionine Polymorphism Increases Compulsive Alcohol Drinking in Mice That Is Reversed by Tropomyosin Receptor Kinase B Activation.

Warnault V, Darcq E, Morisot N, Phamluong K, Wilbrecht L, Massa SM, Longo FM, Ron D.

Biol Psychiatry. 2016 Mar 15;79(6):463-73. doi: 10.1016/j.biopsych.2015.06.007. Epub 2015 Jun 12.


The relationship between alcohol consumption, perceived stress, and CRHR1 genotype on the hypothalamic-pituitary-adrenal axis in rural African Americans.

Obasi EM, Shirtcliff EA, Brody GH, MacKillop J, Pittman DM, Cavanagh L, Philibert RA.

Front Psychol. 2015 Jun 18;6:832. doi: 10.3389/fpsyg.2015.00832. eCollection 2015.


Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction.

Reyes-Gibby CC, Yuan C, Wang J, Yeung SC, Shete S.

BMC Syst Biol. 2015 Jun 5;9:25. doi: 10.1186/s12918-015-0167-x.


Ethnic-specific genetic association of variants in the corticotropin-releasing hormone receptor 1 gene with nicotine dependence.

Tang X, Zhan S, Yang L, Cui W, Ma JZ, Payne TJ, Li MD.

Biomed Res Int. 2015;2015:263864. doi: 10.1155/2015/263864. Epub 2015 Feb 22.


Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.

Phillips TJ, Reed C, Pastor R.

Genes Brain Behav. 2015 Jan;14(1):98-135. doi: 10.1111/gbb.12189. Review.


The central amygdala as an integrative hub for anxiety and alcohol use disorders.

Gilpin NW, Herman MA, Roberto M.

Biol Psychiatry. 2015 May 15;77(10):859-69. doi: 10.1016/j.biopsych.2014.09.008. Epub 2014 Sep 22. Review.

Supplemental Content

Support Center